Commentary: Tempering expectations of screening: what is the most authoritative advice we can give, given the data that we have?

1. Gøtzsche PC, Jørgensen KJ, Zahl PH, Maehlen J. Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control 2012;23:15–21. 2. Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 2013;346:f385. 3. Saquib N, Saquib J, Ioannidis J. Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials. Int J Epidemiol 2015;44:264–77. 4. Gøtzsche PC. Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Health Care. London: Radcliffe Publishing, 2013. 5. Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013;11:106–15. 6. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6:CD001877. 7. Swiss Medical Board. Systematisches Mammographie-Screening. 2013. www.medicalboard.ch/fileadmin/docs/public/mb/Fachberi chte/2013-12-15_Bericht_Mammographie_Final_Kurzfassung_e. pdf (date last accessed, 1 October 2014). 8. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012;10:CD009009. 9. Jørgensen T, Jacobsen RK, Toft U, Aadahl M, Glümer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;348:g3617.